PHGE - BiomX Inc.
Close
0.7081
0 0%
Share volume: 200
Last Updated: Wed 08 Jan 2025 04:43:36 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.38%
PREVIOUS CLOSE
CHG
CHG%
$0.71
0.00
0.00%
View ratios
| Fiscal Date | 2024-09-30 | |
|---|---|---|
| Fiscal Quarter | Q3 2024 | |
| Report Date | 2024-11-14 | |
| Assets | ||
| Total Assets | 59.980 M | |
| Current Assets | 0.000 | |
| Inventories | 0.000 | |
| Other Current Assets | 0.000 | |
| Short Term Investments | 0.000 | |
| Total Receivables | 0.000 | |
| Current Cash | 23.537 M | |
| Total Non-current Assets | 0.000 | |
| Property Plant Equipment | 0.000 | |
| Other Assets | 0.000 | |
| Intangible Assets | 0.000 | |
| Goodwill | 0.000 | |
| Liabilities and shareholders’ equity | ||
| Total Liabilities and shareholders’ equity | 59.980 M | |
| Total liabilities | 22.084 M | |
| Total current liabilities | 0.000 | |
| Accounts Payable | 0.000 | |
| Other liabilities | 0.000 | |
| Current long term debt | 0.000 | |
| Long term debt | 0.000 | |
| Other liabilities | 0.000 | |
| Minority interest | 0.000 | |
| Total Shareholder equity | 19.251 M | |
| Common stock | 185.435 M | |
| Retained earnings | -166.184 M |